Early research (Phase 1)Study completedNCT02401737
What this trial is testing
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients
Who this might be right for
Chronic Hepatitis B
Novira Therapeutics, Inc. 58